Ratios
10-year key figure history for Chordate Medical turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Chordate Medical with index and moving average MA50 and MA200.
Description
Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in selected European markets, Israel and Saudi Arabia. The company’s product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.